Ali G. Abdullah, Ban I. Sedeeq, Marwan S. Azzubaidi
Ali G. Abdullah1, Ban I. Sedeeq2, Marwan S. Azzubaidi3*
1Department of Oral and Maxillofacial Surgery, College of Dentistry, Tikrit University, Iraq.
2Department of Basic Sciences, College of Dentistry, Tikrit University, Iraq.
3Pharmacology Unit, Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia.
Volume - 14,
Issue - 8,
Year - 2021
Coenzyme Q10 (Co-Q10) or ubiquinone plays an important role in the cellular metabolism. The safety profile of ubiquinone as a dietary supplement has been assessed in few sub-chronic toxicity studies. The aim of this study was to evaluate the possible hepatotoxic effect of long-term oral administration of an intermediate oral dose of Co-Q10 in experimental animals. Fifteen Wistar rats were treated with 300mg/kg daily oral doses of Co-Q10 using forced oral feeding for six weeks. Additional 5 healthy rats represented the control group for comparison. All rats were euthanized at the end of the 6th week. Then H and E stained histological sections of rats’ livers revealed vacuolation of hepatocytes, an increase in the diffusion of macrophages and the formation of microgranuloma most probably indicating a drug-induced injury. In conclusion, this study adds evidence supporting the potential hepatotoxic actions resulting from repeated administration of intermediate oral dose of Co-Q10 especially on the long-term.
Cite this article:
Ali G. Abdullah, Ban I. Sedeeq, Marwan S. Azzubaidi. Histopathological Changes in Liver Tissue after repeated administrations of an Intermediate Dose of Coenzyme Q10 to Wistar Rats. Research Journal of Pharmacy and Technology. 2021; 14(8):4025-8. doi: 10.52711/0974-360X.2021.00697
Ali G. Abdullah, Ban I. Sedeeq, Marwan S. Azzubaidi. Histopathological Changes in Liver Tissue after repeated administrations of an Intermediate Dose of Coenzyme Q10 to Wistar Rats. Research Journal of Pharmacy and Technology. 2021; 14(8):4025-8. doi: 10.52711/0974-360X.2021.00697 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-8-3
1. Gajanan D, Suresh BV, Chandrashekar MD, Ravindra KC, Flynn S, Prasad S, et al. Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies. Journal of Toxicology. 2019; 2019: 1-25.
2. Rodick TC, Seibels DR, Babu JR, Huggins KW, Ren G, Mathews ST. Potential role of coenzyme Q10 in health and disease conditions. Nutrition and Dietary Supplements. 2018; 10: 1-11.
3. Ernster L and Dallner G. Biochemical, physiological and medical aspects of ubiquinone function, BBA -Molecular Basis of Disease, vol. 1271, no. 1, pp. 195–204, 1995.
4. Tarry-Adkins JL, Fernandez-Twinn DS, Hargreaves IP, Neergheen V, Aiken CE, Martin-Gronert MS, McConnell JM, Ozanne SE. Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth. The American Journal of Clinical Nutrition. 2016; 103(2): 579–588.
5. Lance J, McCabe S, Clancy RL, Pierce J. Coenzyme Q10 – a therapeutic agent. Medsurg Nursing 2012; 21(6): 367–371.
6. Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutrition Reviews 2013; 71(3): 180–188.
7. A Varela-L´opez, F Giampieri, M Battino, and Quiles JL. Coenzyme Q and its role in the dietary therapy against aging. Molecules. 2016; 21 (3), 373-399.
8. Littarru GP and Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology. 2007; 37(1): 31–37.
9. Borekov´a M, Hojerov´a J, Koprda V and Bauerov´a K. Nourishing and health benefits of coenzyme Q10 - a review. Czech Journal of Food Sciences. 2008; 26(4): 229–241.
10. Tanaka H, Nagata K, Oda S, Edamoto H, Kitano M, Oya K, and Hosoe K. Twenty eight day repeated dose oral toxicity study of water-miscible Coenzyme Q10 preparation in rats. Journal of Health Science. 2005; 51 (3): 346-356.
11. Kitano M, Watanabe D, Oda S, Kubo H, Kishida H, Fujii K, Kitahara M, Hosoe K. Subchronic Oral Toxicity of Ubiquinol in Rats and Dogs. International Journal of Toxicology. 2008; 27(2): 189-215.
12. Abdullah AG, Sedeeq BI, Azzubaidi MS. Histopathological nephrotoxic features of high oral doses of ubiquinone in rats. Curr Issues Phar Med Sci. 2021; 34 (2): 101-104.
13. Zainuddin HZM, Zainuddin LRM. Paracetamol induced liver morphological changes after acute dosing. Research J. Pharm. and Tech. 2015; 8 (4): 382-388.
14. Rao USM, Ahmad BA, Mohd KS, Zin T. Antiulcer activity of musa paradisiaca (banana) tepal and skin extracts in ulcer induced albino mice. 2016; 20 (5): 1203-1216. .
15. Turunen M, Olssonc J and Dallner G. Metabolism and function of coenzyme Q. Biochimica et Biophysica Acta. 2004; 1660 (1-2): 171– 199.
16. Peyron C, Lecoindre P, Chevallier M, Guerrete S & Pagnon A. Vacuolar hepatopathy in 43 French Scottish Terriers: a morphological study. Revue de Médecine Vétérinaire. 2015; 166 (7-8): 176-184
17. Li X, Elwell MR, Ryan AM, and Ochao R. Morphogenesis of Postmortem Hepatocyte Vacuolation and Liver Weight Increases in Sprague-Dawley Rats. Toxicologic Pathology, 31:682–688, 2003.
18. Mohamed DI, Khairy E, Tawfek SS, Habib EK, Fetouh MA. Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat. Biomedicine and Pharmacotherapy. 2019; 109(1): 892–901.
19. Mohr D, Bowry VW, Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochimica et Biophysica Acta. 1992; 1126 (3): 247-54.
20. Tomasetti M, Alleva R, Solenghi MD, and Littaru GP. Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ration as a possible marker of increased risk of atherosclerosis. Biofactors. 1999; 9 (2-4): 231-240.
21. Lamps LW. Hepatic Granulomas: A Review with Emphasis on Infectious Causes. Archives of Pathology and Laboratory Medicine. 2015; 139(7):867-75. doi: 10.5858/arpa.2014-0123-RA.
22. Murli Krishna. Patterns of Necrosis in Liver Disease. Clinical liver disease. 2017; 10 (2): 53-56.